Evidence map›Paper›PMID 41438315›Full record

ArticleClinical diabetes : a publication of the American Diabetes Association2025

Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.

Tim C Lai, Heather P Whitley, Mesfin Genie, Robert H Eckel, Surachat Ngorsuraches

Abstract read
In one paragraph

Article in Clinical diabetes : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tim C LaiDepartment of Health Outcomes Research and Policy, Auburn University Harrison College of Pharmacy, Auburn, AL.ORCID https://orcid.org/0000-0002-5113-491X
Heather P WhitleyDepartment of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Auburn, AL.ORCID https://orcid.org/0000-0001-5124-4484
Mesfin GenieNewcastle Business School, The University of Newcastle, Newcastle, NSW, Australia.
Robert H EckelDivision of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Aurora, CO.
Surachat NgorsurachesDepartment of Health Outcomes Research and Policy, Auburn University Harrison College of Pharmacy, Auburn, AL.ORCID https://orcid.org/0000-0002-2327-224X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although patient preferences are heterogeneous, the out-of-pocket cost and accuracy of continuous glucose monitoring (CGM) systems are the two most important attributes for patients with type 2 diabetes. Surprisingly, receiver screen information is not considered important when choosing a CGM system. Identifying important attributes could facilitate patient-provider communications in choosing a preferred CGM system and potentially increase adherence. Improving patient education on interpreting the information on the receiver screen could enhance the benefit of using CGM.

Identifiers

PMID41438315
PMCPMC12719324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.